Persistent circulating tumor DNA (ctDNA) during neoadjuvant treatment (NAT) of early breast cancer (EBC) indicates high-risk disease. …
Anthony M. George,
Yilun Chen,
Sergii Gladchuk,
Miguel Alcaide,
Hina Dalal,
Pei Meng,
Christian Brueffer,
Hani Saghir,
Siker Kimbung,
Kristina Aaltonen,
Lucia Oton,
Christopher Rushton,
Sofia Birkeälv,
Mats Jönsson,
Sophia Zackrisson,
Ida Skarping,
Daniel Förnvik,
Lina Zander,
Gabriella Honeth,
Samuel Woodhouse,
Karen Howarth,
Åke Borg,
Anna Ehinger,
Martin Malmberg,
Lisa Rydén,
Niklas Loman,
Lao H. Saal